OSI Systems, Inc. Form 10-Q Summary
Business Context and Reporting Period
OSI Systems designs and manufactures specialized electronic systems and components for security and inspection, optoelectronics and manufacturing, and healthcare applications. This unaudited filing covers the quarter and six months ended December 31, 2023, representing fiscal Q2 and year-to-date fiscal 2024. Comparisons are with the corresponding fiscal 2023 periods.
Key Financial Metrics
| Metric | Three Months Ended Dec. 31, 2023 | Year-over-Year Change | Six Months Ended Dec. 31, 2023 | Year-over-Year Change |
|---|---|---|---|---|
| Net revenue | $373.2 million | 26.3% | $652.4 million | 15.7% |
| Gross profit | $141.3 million | 46.9% | $240.0 million | 30.7% |
| Gross margin | 37.9% | Up from 32.5% | 36.8% | Up from 32.6% |
| Operating income | $52.3 million | 105.3% | $74.9 million | 71.0% |
| Net income | $36.6 million | 123.5% | $49.4 million | 79.2% |
| Diluted EPS | $2.11 | Up from $0.96 | $2.87 | Up from $1.61 |
Six-month operating margin was 11.5%, compared with 7.8% in the prior-year period. Six-month net margin was 7.6%, compared with 4.9% previously. The effective tax rate was 20.2% for the quarter and 21.0% year to date, including a $2.3 million benefit from changes in prior-year tax estimates during the six-month period.
- Revenue mix: Security revenue increased 32.7% year to date to $414.6 million and represented 63.6% of consolidated revenue. Optoelectronics and Manufacturing revenue declined 3.6% to $158.2 million, while Healthcare revenue declined 8.7% to $79.6 million.
- Cash flow: Cash used in operating activities was $6.4 million year to date, compared with $8.2 million provided in the prior-year period. The decline primarily reflected a $103.3 million increase in inventories, associated with international Security contracts.
- Investing: Cash used in investing activities was $21.8 million, including $9.0 million for acquisitions, $8.7 million for property and equipment, and $8.4 million for intangible and other assets.
- Liquidity: Cash and cash equivalents were $127.3 million at December 31, 2023, up from $76.8 million at June 30, 2023. Approximately 92% was held by foreign subsidiaries and may be subject to repatriation tax considerations.
- Debt: Revolving credit borrowings were $316.0 million, term-loan borrowings were $139.4 million, and foreign bank-line borrowings were $57.5 million. The company reported $230.0 million available under the revolving facility after outstanding letters of credit. It was in compliance with its financial covenants.
- Contract backlog indicator: Remaining performance obligations were approximately $928.2 million at December 31, 2023; approximately 66% was expected to be recognized over the next 12 months.
Material Changes Versus the Prior Comparable Period
- Security revenue growth, particularly cargo and vehicle inspection systems, drove the majority of consolidated growth. Security also benefited from improved mix and economies of scale, lifting gross margins.
- Healthcare revenue declined, primarily because of lower patient-monitoring sales. Healthcare is described as the company’s highest-gross-margin division, so its lower sales partially offset margin expansion elsewhere.
- SG&A increased 32.6% in the quarter and 22.3% year to date, driven primarily by higher employee compensation, professional services, accounts-receivable loss provisions, and certain contingent earnout valuation changes.
- Interest and other expense increased to $12.3 million year to date from $8.6 million, reflecting higher interest rates and higher average borrowings. The interest-rate swap provided a $1.8 million year-to-date benefit.
- Restructuring and other charges declined to $1.5 million year to date from $3.5 million, as prior-year charges included approximately $2.9 million of legal costs primarily related to government investigations.
- The company made no share repurchases during the six months ended December 31, 2023, compared with $21.8 million of repurchases in the prior-year period.
- Two fiscal 2024 acquisitions were completed for approximately $9.1 million in aggregate, excluding potential contingent consideration: a contract manufacturer acquired in December 2023 and a radiation-detection technology provider acquired in October 2023.
Guidance, Outlook, Risks, and Unusual Items
The filing does not provide specific quantitative revenue or earnings guidance. Management stated that available cash, credit facilities, and expected operating cash flow should be sufficient for operational needs over the next 12 months and thereafter for the foreseeable future.
- Management highlighted two significant international Security contracts awarded in fiscal 2023 with aggregate value exceeding $700 million and revenue expected over multiple years.
- Key risks include government budget and procurement delays, potential U.S. government shutdown effects, contract cancellations or delayed customer acceptance, global supply-chain and component constraints, inflation, labor shortages, foreign-exchange volatility, cybersecurity threats, and geopolitical conflicts including Russia-Ukraine and Israel-Hamas.
- One Security customer represented 18% of quarterly revenue, 14% of year-to-date revenue, and 12% of accounts receivable at December 31, 2023, creating customer-concentration exposure.
- Potential capped acquisition earnout payments totaled up to $48.7 million; the recorded contingent-consideration liability was $19.7 million at December 31, 2023.
- A $13.5 million bonus payable to the CEO during the quarter ending March 31, 2024 was accrued in connection with the CEO’s employment agreement.
- The company is cooperating with a Department of Justice subpoena concerning a former employee and business dealings in Mexico. Management has not accrued a loss contingency, but states that an adverse resolution of legal or environmental matters could materially affect results.
- Inventory increased to $445.8 million from $338.0 million at June 30, 2023, while unbilled revenue increased 79% to $155.5 million, primarily because of Security contract milestones recognized before billing rights arose.
Most Important Facts for Investors to Verify
- Whether Security contract execution and customer acceptance support the elevated revenue, inventory, and unbilled-revenue balances.
- The timing and profitability of the international contracts and the conversion of the $928.2 million remaining performance obligations into revenue and cash.
- Operating cash flow and working-capital normalization, particularly inventory levels and accounts receivable collections.
- Interest-rate exposure, revolving-credit utilization, available borrowing capacity, and continued compliance with debt covenants.
- The effect of customer concentration, government procurement cycles, supply-chain constraints, and geopolitical conditions on future orders.
- Potential cash payments for acquisition earnouts, the $13.5 million CEO bonus, environmental matters, and ongoing legal proceedings.
- The sustainability of improved gross margins given the lower Healthcare contribution and higher SG&A expense.